Litcius/Paper detail

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

Brendan M. Everett, Jean MacFadyen, Tom Thurén, Peter Libby, Robert J. Glynn, Paul M. Ridker

2020Journal of the American College of Cardiology201 citationsDOI

Topics & Concepts

CanakinumabMedicineMyocardial infarctionPlaceboInternal medicineConfidence intervalRandomized controlled trialAdverse effectCardiologyDiseaseAnakinraPathologyAlternative medicineInflammasome and immune disordersAtherosclerosis and Cardiovascular DiseasesAdipokines, Inflammation, and Metabolic Diseases
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial | Litcius